Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Nature Communications
|
April 12, 2025
Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer
Ranjan Preet, Md Atiqul Islam, Jiyoung Shim, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 31, 2006
AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles
Rashna Madan, Robert Gormley, Alina Dulau, et al.
Cancer Medicine
|
June 16, 2023
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma
Weijing Sun, Nirmal Veeramachaneni, Raed Al-Rajabi, et al.
Head & Neck
|
June 20, 2006
Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma
Rashna Madan, Margaret Brandwein-Gensler, Nicolas F Schlecht, et al.
Cell Reports. Medicine
|
January 26, 2023
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results
Anwaar Saeed, Robin Park, Junqiang Dai, et al.
American Journal of Clinical Pathology
|
October 6, 2005
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases
Robert P Gormley, Rashna Madan, Alina E Dulau, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 3, 2019
Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer
Merit L Goodman, Gloria M Trinca, Katherine R Walter, et al.
Nature Communications
|
February 20, 2024
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort
Anwaar Saeed, Robin Park, Harsh Pathak, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 27, 2025
Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer
Shane R Stecklein, Roberto Salgado, Julia R White, et al.
Translational Medicine Communications
|
April 15, 2025
A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors
Joaquina C Baranda, Ghulam Rehman Mohyuddin, Andrés M Bur, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Nature Communications
|
April 12, 2025
Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer
Ranjan Preet, Md Atiqul Islam, Jiyoung Shim, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 31, 2006
AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles
Rashna Madan, Robert Gormley, Alina Dulau, et al.
Cancer Medicine
|
June 16, 2023
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma
Weijing Sun, Nirmal Veeramachaneni, Raed Al-Rajabi, et al.
Head & Neck
|
June 20, 2006
Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma
Rashna Madan, Margaret Brandwein-Gensler, Nicolas F Schlecht, et al.
Cell Reports. Medicine
|
January 26, 2023
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results
Anwaar Saeed, Robin Park, Junqiang Dai, et al.
American Journal of Clinical Pathology
|
October 6, 2005
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases
Robert P Gormley, Rashna Madan, Alina E Dulau, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 3, 2019
Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer
Merit L Goodman, Gloria M Trinca, Katherine R Walter, et al.
Nature Communications
|
February 20, 2024
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort
Anwaar Saeed, Robin Park, Harsh Pathak, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 27, 2025
Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer
Shane R Stecklein, Roberto Salgado, Julia R White, et al.
Translational Medicine Communications
|
April 15, 2025
A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors
Joaquina C Baranda, Ghulam Rehman Mohyuddin, Andrés M Bur, et al.
Page
of 5